首页> 外文期刊>Therapeutic Drug Monitoring >Determination of sirolimus blood concentration using high-performance liquid chromatography with ultraviolet detection.
【24h】

Determination of sirolimus blood concentration using high-performance liquid chromatography with ultraviolet detection.

机译:使用高效液相色谱-紫外线检测法测定西罗莫司血药浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Different HPLC methods have been developed and used to determined sirolimus blood concentrations. These methods show different performance characteristics, mostly related to peak interference, recovery, assay sensitivity, and turnaround times. OBJECTIVE: We adapted, improved, and validated an HPLC method with UV detection for measurement of sirolimus in whole blood clinical samples. METHODS: The standards, quality controls, or patient samples (0.25 or 0.5 mL) and internal standard (desmethoxysirolimus) were extracted with 1-chlorobutane. After evaporation, the extract was reconstituted in a 70% acetonitrile/water mixture and analyzed onto a reverse-phase C18 column at 50 degrees C under a flow rate of 1.0 mL/min in the HPLC system. Ultraviolet detection was performed at 278 nm, with sensitivity setting of 0.010 AUFS. Identification of peaks of interest was by retention time; quantification of sirolimus was based on a peak area ratio. RESULTS: Analytic recovery ranging from 96 to 120% (CV = 3.7 to 16.8%; bias = -4.2 to 16.7%) was observed throughout the assay's linear range (2.5-150.0 ng/mL). The lower limit of quantification for both sample volumes (0.25 or 0.5 mL) was 2.5 ng/mL (CV = 12 and 15%, bias = -1.2 and 4%, respectively). The intra- and interassay imprecision ranged from 6.2 to 14.4% and from 9.1 to 18.6%, with bias ranging from 1.3 to 12.9% and -1.8% to 7.1, for quality control levels of 3, 10, and 20 ng/mL. Whole blood and extracted samples are stable at room temperature and at 4 and -20 degrees C for 1 week and 3 days, respectively. Chromatograms showed good separation free of interfering peaks. A set of 45 samples can be extracted in 2 h, allowing results within 24 h. CONCLUSION: This HPLC-UV method shows good and reproducible performance, satisfying all requirements of an assay designated to be applied in therapeutic drug monitoring strategies after organ transplantation.
机译:背景:已开发出不同的HPLC方法并将其用于测定西罗莫司的血药浓度。这些方法显示出不同的性能特征,主要与峰干扰,回收率,测定灵敏度和周转时间有关。目的:我们采用紫外线检测法对全血临床样品中西罗莫司的测量进行了改进,改进和验证,该方法适用于HPLC。方法:用1-氯丁烷提取标准品,质量控制样品或患者样品(0.25或0.5 mL)和内标物(去甲氧基西罗莫司)。蒸发后,将萃取液重新溶解在70%乙腈/水混合物中,并在HPLC系统中以50 mL的温度在1.0 mL / min的流速下分析到反相C18柱上。在278 nm处进行紫外线检测,灵敏度设置为0.010 AUFS。通过保留时间鉴定目标峰。西罗莫司的定量基于峰面积比。结果:在整个测定的线性范围内(2.5-150.0 ng / mL)观察到的分析回收率为96%至120%(CV = 3.7至16.8%;偏差= -4.2至16.7%)。两种样品体积(0.25或0.5 mL)的定量下限均为2.5 ng / mL(CV分别为12%和15%,偏差= -1.2和4%)。对于3、10和20 ng / mL的质量控制水平,批内和批间不准确度在6.2%至14.4%和9.1%至18.6%之间,偏差在1.3%至12.9%和-1.8%至7.1%之间。全血和提取的样品分别在室温,4和-20摄氏度下稳定1周和3天。色谱图显示出良好的分离效果,没有干扰峰。可以在2小时内提取45组样品,从而在24小时内得到结果。结论:该HPLC-UV方法显示出良好且可重复的性能,满足器官移植后指定用于治疗性药物监测策略的所有测定要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号